Anti-Cancer Stem Cell Properties of Square Planar Copper(II) Complexes with Vanillin Schiff Base Ligands

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Materials Science

Background:

• Current breast cancer therapies have limited efficacy, with a 24% 10-year mortality rate.
• Breast cancer stem cells (CSCs) drive relapse and metastasis, contributing significantly to mortality.
• Redox-modulating metal complexes offer a potential strategy to target and eliminate CSCs.

Purpose of the Study:

• To synthesize and evaluate novel copper(II) complexes with vanillin Schiff base ligands as anti-breast CSC agents.
• To investigate the structure-activity relationship of these copper(II) complexes against breast CSCs.
• To elucidate the mechanism of action for the most potent complex.

Main Methods:

• Synthesis of four copper(II) complexes with regioisomeric vanillin Schiff base ligands.
• X-ray crystallography to determine the coordination geometry of the complexes.
• In vitro evaluation of anti-breast CSC potency and mechanistic studies (ROS levels, apoptosis pathways).

Main Results:

• Copper(II) complexes 1-4 were synthesized and characterized, exhibiting square planar geometries.
• Complex 4 demonstrated significant potency against breast CSCs, outperforming existing treatments like salinomycin and cisplatin.
• Mechanistic studies revealed that complex 4 induces apoptosis in CSCs via elevated reactive oxygen species and JNK/p38 pathway activation.

Conclusions:

• The synthesized copper(II) complexes represent a promising new class of anti-breast CSC agents.
• Complex 4 exhibits superior efficacy and a well-defined mechanism of action involving oxidative stress and apoptosis.
• This research expands the arsenal of targeted therapies against breast cancer metastasis and relapse.